Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.16 - $6.41 $74,240 - $410,240
-64,000 Reduced 99.53%
300 $0
Q4 2022

Feb 14, 2023

BUY
$4.78 - $15.01 $190,244 - $597,398
39,800 Added 162.45%
64,300 $339,000
Q3 2022

Oct 26, 2022

BUY
$10.22 - $23.7 $250,390 - $580,650
24,500 New
24,500 $285,000
Q1 2022

Apr 20, 2022

BUY
$4.55 - $6.41 $98,280 - $138,456
21,600 New
21,600 $273,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $52.1M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.